Harbor Capital Advisors, Inc. Ptc Therapeutics, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 47,380 shares of PTCT stock, worth $1.5 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
47,380
Previous 34,054
39.13%
Holding current value
$1.5 Million
Previous $991,000
46.22%
% of portfolio
0.11%
Previous 0.13%
Shares
5 transactions
Others Institutions Holding PTCT
# of Institutions
198Shares Held
83.7MCall Options Held
192KPut Options Held
129K-
Vanguard Group Inc Valley Forge, PA9.37MShares$297 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.9MShares$282 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.57MShares$240 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.42MShares$236 Million3.47% of portfolio
-
Armistice Capital, LLC New York, NY6.76MShares$215 Million2.68% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.27B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...